Medicinal Cannabis – Limits on Prescribing

The Chief Medical Officer, National Medical Director and Chief Pharmaceutical Officer have written to GPs to explain changes to regulations […]

Self-Monitoring of Blood Glucose in Type 2 Diabetes – little if any benefit for most

The NHS National Institute for Health Research has published a SIGNAL article highlighting a systematic review of 24 studies (including 5,454 […]

Bath Additives for Children with Eczema – No Benefit

A large (n = 482) well-conducted trial based in UK primary care has found “no evidence of clinical benefit of […]

Keep Antibiotics Working – 2018 Refresh

Public Health England have refreshed & relaunched the Keep Antibiotics Working Campaign for the 2018/19 autumn/winter season – to help […]

Gabapentin & Pregabalin – to be Controlled Drugs in 2019

The Home Office has announced plans to classify both gabapentin and pregabalin as Class C controlled drugs in April 2019. […]

Jext Adrenaline Auto-Injectors – Extended Use By Dates

The MHRA have authorised ALK to extend the use by dates of specified Lots (Batches) of Jext 150 microgram adrenaline […]

Adrenaline 150microgram Auto-injectors – Supply Controls

The Department of Health & Social Care (DHSC) has put in place a Dispenser Validation process for all prescriptions for […]

NHS England Press Release – Adalimumab Patent Expiry

NHS England have issued a Press Release announcing that the NHS is set “to save £150 million by switching to new […]

Prevention of Future Deaths Report – Adrenaline Auto-Injectors

A recent post noted that HM Assistant Coroner for West London intended to issue a Regulation 28 Prevention of Future […]